Rigorous testing vs timely approval: a review of the US FDA approval process
From 1983–2018, the way in which drugs were approved adapted and evolved, leading to more generic drugs and biological approvals and more drug manufacturers taking advantage of an expedited review process.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>